Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States.

Sepassi, Aryana; Saunders, Ila M; Bounthavong, Mark; Taplitz, Randy A; Logan, Cathy; Watanabe, Jonathan H

Sepassi, Aryana; Saunders, Ila M; Bounthavong, Mark; Taplitz, Randy A; Logan, Cathy; Watanabe, Jonathan H.

Afiliación

Sepassi A; Department of Clinical Pharmacy Practice, University of California, Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, CA, USA. asepassi@hs.uci.edu.
Saunders IM; Division of Clinical Pharmacy, University of California, San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences, La Jolla, CA, USA.
Bounthavong M; Division of Clinical Pharmacy, University of California, San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences, La Jolla, CA, USA.
Taplitz RA; Department of Veteran Affairs, Health Economic Resource Center, Menlo Park, CA, USA.
Logan C; Department of Medicine, City of Hope, Duarte, CA, USA.
Watanabe JH; Division of Infectious Diseases and Global Health, University of California, San Diego, La Jolla, CA, USA.

Pharmacoecon Open ; 7(3): 393-404, 2023 May.

Article en En | MEDLINE | ID: mdl-36840894

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Pharmacoecon Open Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google